Buy (150 RUB)
Generate QR code
Open Access
Subscription or Fee Access
Diagnosis of decreased segmental deformation of the left ventricular myocardium in a teenager at the early stage of hypertrophic cardiomyopathy (clinical observation)
https://doi.org/10.33667/2078-5631-2024-22-29-33
Abstract
The article presents a clinical observation that revealed a decrease in segmental deformation of the left ventricular myocardium in a 15-year-old teenager at the early stage of asymmetric non-obstructive hypertrophic cardiomyopathy (HCM). To assess myocardial systolic function, the following were used: ejection fraction and shortening of the left ventricle, as well as indicators of global and segmental myocardial deformation, determined by echocardiographic study using the 2D speckle-tracking method. There was no change in ejection fractions and shortening of the left ventricle, global longitudinal deformation of the myocardium, but there was a decrease in longitudinal and circular deformation in individual segments of the left ventricle, which, in general, was the basis for prescribing cardioprotective therapy.
About the Authors
O. S. Groznova
Veltischev Research and Clinical Institute for Pediatrics and Pediatric Surgery of the Pirogov Russian National Research Medical University;
Charity Fund for medical and social genetic aid projects «Life Genome»;
Department of Innovative Pediatrics and Pediatric Surgery, Institute of Continuing Education and Professional Development of the Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
Groznova Olga Sergeevna, Dr. Med. Sc., сhief Researcher of the Department of Pediatric Cardiology and Arrhythmology, director, Professor of the Department of Innovative Pediatrics and Pediatric Surgery
Moscow
A. A. Tarasova
Russian Medical Academy of Continuing Professional Education of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Tarasova Alla Alekseevna, Dr. Med. Sc., Professor, Professor of the Department of Radiation Diagnostics of children
Moscow
E. G. Verchenko
Veltischev Research and Clinical Institute for Pediatrics and Pediatric Surgery of the Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
Verchenko Elena Gennadievna, Cand. Med. Sc., ultrasound diagnostics doctor of the Department of functional diagnostics of cardiac arrhythmias
Moscow
V. V. Bereznitskaya
Veltischev Research and Clinical Institute for Pediatrics and Pediatric Surgery of the Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
Bereznitskaya Vera Vasilievna, Cand. Med. Sc., Head of the Pediatric Cardiology Department of Cardiac Arrhythmias
Moscow
References
1. Colan S.D., R. Margossian R. Hypertrophic Cardiomyopathy. Chapter 19 in Heart Failure in the Child and Young Adult. Copyright © 2018 Elsevier Inc. All rights reserved. http://dx.doi.org/10.1016/B978-0-12-802393-8.00019-3.
2. Alexander PMA, Nugent AW, Daubeney PEF et al. National Australian Childhood Cardiomyopathy Study. Long-term outcomes of hypertrophic cardiomyopathy diagnosed during childhood: results from a national population-based study // Circulation. – 2018. – Vol. 138 (1). – P. 29–36. doi:10.1161/CIRCULATIONAHA.117.028895.
3. Norrish G., Field E., Mcleod K. et al. Clinical presentation and survival of childhood hypertrophic cardiomyopathy: a retrospective study in United Kingdom // Eur Heart J. – 2019. – Vol. 40 (12). – P. 986–993. doi:10.1093/eurheartj/ehy798.
4. Leontyeva I.V., Kovalev I.A. Prognosis for hypertrophic cardiomyopathy in children // Pediatria n.a. G.N. Speransky. – 2020. – 99 (3). P. 235–244. [in Russian].
5. Clinical recommendations of the Ministry of Health of the Russian Federation. Hypertrophic cardiomyopathy. 2023. 167 p.
6. Bharucha T., Lee K.J., Daubeney PEF et al. Sudden death in childhood cardiomyopathy: Results from a long-term national population-based study // J Am Coll Cardiol. – 2015. – Vol. 65 (21). – P. 2302–2310. doi: 10.1016/j.jacc.2015.03.552.
7. Goff Z.D., Calkins H. Sudden death related cardiomyopathies – hypertrophic cardiomyopathy // Prog Cardiovasc Dis. – 2019. – Vol. 62 (3). – P. 212-216. doi: 10.1016/j.pcad.2019.04.001.
8. Rowin EJ, Sridharan A., Madias C. et al. Prediction and Prevention of Sudden Death in Young Patients ( <20 years) With Hypertrophic Cardiomyopathy // Am J Cardiol. – 2020. – Vol. 128. –P. 75-83. doi: 10.1016/j.amjcard.2020.04.042.
9. Chaudhry-Waterman N., Cohen M.I. Newer risk assessment strategies in hypertrophic cardiomyopathy // Curr Opin Cardiol. – 2021. – Vol. 36 (1). P. 80-88. doi: 10.1097/HCO.0000000000000804.
10. Norrish G., Ding T., Field E. et al. Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids) // JAMA Cardiol. – 2019. – Vol. 4 (9). – P. 918–927. doi:10.1001/jamacardio.2019.2861.
11. Towbin J.A., McKenna W.J., Abrams D.J. et al. HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy // Heart Rhythm. – 2019. – Vol. 16 (11). – P. e301-e371. doi: 10.1016/j.hrthm.2019.05.007
12. Mitchell C., Rahko P.S., Blauwet L.A. et al. Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the american society of echocardiography // J Am Soc Echocardiogr. – 2019. – Vol. 32 (1). – P. 1-64. doi: 10.1016/j.echo.2018.06.004.
13. Norrish G., Kaski J.P. Risk stratification in childhood hypertrophic cardiomyopathy // Global Cardiology Science and Practice. – 2018. – Vol. 3. – P. 24. doi:10.21542/gcsp.2018.24.
14. Parato V.M., Antoncecchi V., Sozzi F. et al. Echocardiographic diagnosis of the different phenotypes of hypertrophic cardiomyopathy (Italian Chapter of ISCU) // Cardiovasc Ultrasound. – 2016. – Vol. 14 (1). – P. 30. doi: 10.1186/S12947-016-0072-5.
15. Voigt J.U., Pedrizzetti G., Lysyansky P. et al. Denitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ ASE/Industry Task Force to standardize deformation imaging // Eur. Heart J Cardiovasc Imaging. – 2015. – Vol. 16 (1). – P. 1–11. doi: 10.1093/ehjci/jeu184.
16. Alekhin M.N. Two-dimensional speckle-tracking echocardiography for the assessment of myocardial deformity and heart chambers. Textbook. Moscow: Publishing house Vidar-M, 2022. 112 p.
17. Bokeria L.A., Alekhine M.N., Mashina T.V., etc. Modern ultrasound technologies in cardiology and cardiac surgery. Moscow: Federal State Budgetary Institution «NMICSSH named after A.N. Bakulev» Ministry of Health of the Russian Federation, 2018. 140 p.
18. Baudry G., Mansencal N., Reynaud A. et al. Global and regional echocardiographic strain to assess the early phase of hypertrophic cardiomyopathy due to sarcomeric mutations // Eur Heart J Cardiovasc Imaging. – 2020. – Vol. 21 (3). – P. 291–298. doi: 10.1093/ehjci/jez084.
19. Huang J., Yan Z.N., Rui Y.F. et al. Left ventricular short-axis systolic function changes in patients with hypertrophic cardiomyopathy detected by two-dimensional speckle tracking imaging // BMC Cardiovasc Disord. – 2018. – Vol. 18(1). – P. 13. doi: 10.1186/s12872-018-0753-0.
20. Yang Y., Wu D., Wang H. et al. Prognostic value of global longitudinal strain in hypertrophic cardiomyopathy: A systematic review and meta-analysis // Clin Cardiol. – 2022. –Vol. 45 (12). – P.1184-1191. doi: 10.1002/clc.23928.
21. Arad M., Penas-Lado M., Monserrat L. et al. Gene mutations in apical hypertrophic cardiomyopathy // Circulation. – 2005. – Vol. 112 (18). – P. 2805-2811. doi: 10.1161/CIRCULATIONAHA.105.547448
Review
For citations:
Groznova O.S., Tarasova A.A., Verchenko E.G., Bereznitskaya V.V. Diagnosis of decreased segmental deformation of the left ventricular myocardium in a teenager at the early stage of hypertrophic cardiomyopathy (clinical observation). Medical alphabet. 2024;(22):29-33. (In Russ.) https://doi.org/10.33667/2078-5631-2024-22-29-33
Views:
85
Email this article 